Top stories in Prince Edward Island
Local
MoreOpinion
MoreBusiness
MoreLifestyles
MoreSports
MoreCanada
MoreWorld
MoreFDA approves Neurocrine Biosciences' Huntington's disease drug
(Reuters) - The U.S. Food and Drug Administration (FDA) has approved granule formulation of Neurocrine Biosciences' drug to treat movement disorders associated with Huntington's disease, the company said on Tuesday. (Reporting by Sruthi ...
Updated 5 minutes ago
|1 min read